117 related articles for article (PubMed ID: 21483400)
1. [Comparison of a new medical device with domperidone in functional dyspepsia: a randomized, cross-over, controlled study].
Gallo A; Giovinale M; Fonnesu C; Covino M; Montalto M; Gasbarrini G
Minerva Med; 2011 Apr; 102(2):133-9. PubMed ID: 21483400
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis.
Veldhuyzen van Zanten SJ; Jones MJ; Verlinden M; Talley NJ
Am J Gastroenterol; 2001 Mar; 96(3):689-96. PubMed ID: 11280535
[TBL] [Abstract][Full Text] [Related]
3. [Combination therapy of azintamid and domperidone in functional dyspepsia: a randomised, double-blind, placebo-controlled trial].
Zhao L; Xu L; Li Q; Wang XD; Wang DM; Wang ZG
Zhonghua Nei Ke Za Zhi; 2011 Mar; 50(3):212-5. PubMed ID: 21600084
[TBL] [Abstract][Full Text] [Related]
4. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride.
Halter F; Staub P; Hammer B; Guyot J; Miazza BM
J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of Combizym in the treatment of Chinese patients with dyspepsia: a multicenter, randomized, placebo-controlled and cross-over study: Shanghai Combizym Clinical Cooperative Group.
Ran ZH; Yuan YZ; Li ZS; Wang JY; Zong CH; Xie WF; Zheng P; Chen SL; Zhan XB; Chen SY; Xiao SD
J Dig Dis; 2009 Feb; 10(1):41-8. PubMed ID: 19236546
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia.
Kato M; Watanabe M; Konishi S; Kudo M; Konno J; Meguro T; Kitamori S; Nakagawa S; Shimizu Y; Takeda H; Asaka M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():27-31. PubMed ID: 15943843
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.
Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Nishi N; Chayama K; Haruma K
J Gastroenterol Hepatol; 2007 Mar; 22(3):304-10. PubMed ID: 17295758
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a simethicone, activated charcoal and magnesium oxide combination (Carbosymag®) in functional dyspepsia: results of a general practice-based randomized trial.
Coffin B; Bortolloti C; Bourgeois O; Denicourt L
Clin Res Hepatol Gastroenterol; 2011 Jun; 35(6-7):494-9. PubMed ID: 21478070
[TBL] [Abstract][Full Text] [Related]
9. Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin.
Arai M; Matsumura T; Tsuchiya N; Sadakane C; Inami R; Suzuki T; Yoshikawa M; Imazeki F; Yokosuka O
Hepatogastroenterology; 2012; 59(113):62-6. PubMed ID: 22260823
[TBL] [Abstract][Full Text] [Related]
10. Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis.
Yang YJ; Bang CS; Baik GH; Park TY; Shin SP; Suk KT; Kim DJ
BMC Gastroenterol; 2017 Jun; 17(1):83. PubMed ID: 28651565
[TBL] [Abstract][Full Text] [Related]
11. Review article: endpoints used in functional dyspepsia drug therapy trials.
Ang D; Talley NJ; Simren M; Janssen P; Boeckxstaens G; Tack J
Aliment Pharmacol Ther; 2011 Mar; 33(6):634-49. PubMed ID: 21223343
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic strategies for the treatment of dyspepsia.
Kandulski A; Venerito M; Malfertheiner P
Expert Opin Pharmacother; 2010 Oct; 11(15):2517-25. PubMed ID: 20726822
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of an activated charcoal-simethicone combination in dyspeptic syndrome: results of a randomized prospective study in general practice.
Lecuyer M; Cousin T; Monnot MN; Coffin B
Gastroenterol Clin Biol; 2009; 33(6-7):478-84. PubMed ID: 19349130
[TBL] [Abstract][Full Text] [Related]
14. Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial.
Corazza GR; Biagi F; Albano O; Bianchi Porro G; Cheli R; Mazzacca G; Miglio F; Naccarato R; Quaglino D; Surrenti C; Verme G; Gasbarrini G
Ital J Gastroenterol; 1996; 28(6):317-23. PubMed ID: 8891846
[TBL] [Abstract][Full Text] [Related]
15. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia.
Holtmann G; Gschossmann J; Mayr P; Talley NJ
Aliment Pharmacol Ther; 2002 Sep; 16(9):1641-8. PubMed ID: 12197843
[TBL] [Abstract][Full Text] [Related]
16. [A randomized controlled Multi-center clinical trial on mosapride in the treatment of functional dyspepsia].
Chen SY; Wang JY; Zhu CW; Yuan YZ; Zou B; Xia L; Liu JY; Xu HW; Zhang SZ; Wang Q; Xie XJ; Zhao ZQ; Lin L; Hu NZ; Xu JM
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Feb; 25(2):165-8. PubMed ID: 15132875
[TBL] [Abstract][Full Text] [Related]
17. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials.
Talley NJ; Tack J; Ptak T; Gupta R; Giguère M
Gut; 2008 Jun; 57(6):740-6. PubMed ID: 17965059
[TBL] [Abstract][Full Text] [Related]
18. [Levosulpiride versus domperidone in the treatment of functional dyspepsia].
Mangiameli A; Brogna A; Catanzaro R; Sofia M; Blasi A
Clin Ter; 1994 Feb; 144(2):107-14. PubMed ID: 7910127
[TBL] [Abstract][Full Text] [Related]
19. [Single blind trial with domperidone in orally soluble granulates in patients with functional dyspepsia treated with H2 blockers].
Garzia G
Boll Chim Farm; 1988 Jan; 127(1):6S-8S. PubMed ID: 2905890
[No Abstract] [Full Text] [Related]
20. Criteria used by general practitioners in prescribing prokinetic or antisecretory drugs in patients with functional dyspepsia.
Monés J; Guilera M; Artés M; López JS; Guerrero T; Fillat O;
Rev Esp Enferm Dig; 2001 May; 93(5):281-92. PubMed ID: 11488106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
